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Human skin chymotrypsin-like proteinase, human 
neutrophil cathepsin G, rat mast cell chymase, and rat 
salivary gland tonin are cell-derived serine proteinases 
of similar size with specificity for amino acids of aro-
matic residues. Each enzyme was examined for its abil-
ity to convert angiotension I to angiotensin II and to 
cleave a panel of synthetic substrates. Skin chymotryp-
tic proteinase, cathepsin G, and tonin cleaved the phe8 -
his, bond of angiotensin I a nd converted angiotensin I 
to angiotensin II without further degradation. In con-
trast, chymase formed relatively small amounts of an-
giotensin II because it preferentially cleaved the tyr.-
iler. bond of angiotensin I. The rank order of angiotensin 
I converting activity was skin chymotryptic proteinase 
> tonin > cathepsin G > chymase. The K., and Kcu• for 
a ngiotensin I conversion by the human skin enzyme 
were 6 .6 x 10-5 M and 50 s- 1 , respectively. The angi-
otensin I converting activity of human sldn chymotryp-
tic proteinase is equal to or greater than the peptidyl 
dicarboxypeptidase a ngiotensin-converting enzyme. 
S ubstrate specificities of each enzyme were further dis-
tinguished by use of benzoyl-L-tyrosine ethyl ester. A 
limited immunologic characterization of each enzyme 
was performed with monospecific goat antiserum to ca-
thepsin G and chymase by Ochterlony gel diffusion. Each 
antiserum gave a precipitin line against its respective 
immunogen without evidence of cross-reactivity against 
the other enzymes. Human skin chymotryptic protein-
ase, cathepsin G, and tonin provide unique pathways for 
the generation of angiotensin II in tissue and may be of 
significance in regulation of biologic processes of the 
tissue microenvironment. The kinetic constants of the 
human skin chymotryptic proteinase for angiotensin I 
conversion, are consistent with the potential to carry 
out a reaction of physiologic importance. 
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Abbrev iations: 
ACE: a ngiotensin -convert ing enzyme 
BTEE: benzoyl-L-tyrosine ethyl ester 
bz-a rg-pro-phe-p-NA: benzoyl-r.-arginine- L-proline-L-phenylala-
nine-p-NA 
CM: ca rboxy methyl 
DFP: diisopropyl flu orophosphate 
DTME: n-tryptopha n methyl ester 
1-IPLC: high-perform ance liquid chromatography 
p-N A: pa rani troanilide 
suc-a rg-pro-ty r-p -N A: succi nyi-L-a rginine· L-p roline-L-tyrosin e-
p-NA 
Chymotrypsin- like activit ies have been identifi ed in rat [1 ,2] 
and human [1 ,3] skin. In rat this activity has been primarily 
localized to connective tissue mast cells. The human skin 
enzyme has been highly purified and its level is 15-fold higher 
than normal in skin of patients with mastocytosis [4]. Other 
ce llular chymotrypsin-like proteinases have been identified in 
the human and rat. These include human leukocyte cathepsin 
G [5), rat mast cell chymase (proteinase I) [6), and rat salivary 
gland tonin [7]. Each of these enzymes is a 28,000-30,000 Mr 
serine proteinase whose biologic functions is unclear. 
Angiotensin II is a vasoactive octapeptide thought to be 
generated in se rum by a two-step reaction in which renin 
releases t he decapeptide angiotensin I from angiotensinogen 
[8]. Angiotensin I is subsequently converted to angiotensin II 
by cleavage of a phex- hisu bond by the dipept idyl carboxypep-
tidase angiotensin-converti ng enzyme (ACE) [9] . The ex istence 
of alternative angiotensin II form ing pathways was init ially 
suggested by the observation that a rat submaxillary gland 
enzyme efficiently formed angiotensin II from a synthetic te-
t radecapeptide renin substrate or from angiotensin I [7]. The 
enzyme has been designated "tonin" and is a single polypeptide 
chain 28,700 Mr serine proteinase which has significant se-
quence homology with t he ')'-subunit of nerve growth factor 
and epidermal growth factor binding protein [10) . Recent ly, 
human leukocyte catheps in G [11- 13] and the human skin 
chymotryptic proteinase [14), have been shown to rapidly gen-
erate angiotens in II in the absence of renin or ACE. These 
observations have led to the speculation that angiotensin II 
formation in the tissue microenvironment may occur by ACE 
independent pathways [13,14]. 
We have compared the action of human sk in chymotryptic 
proteinase, human leukocyte cathepsin G, rat salivary gland 
ton in , and rat mast cell chymase on angiotensin I and the 
synthetic substrate benzoyi-L-tyrosine ethyl ester (BTEE). In 
addition , t he immunologic cross-reactivities of the 4 proteinases 
have been studied. The functional and immunologic evidence 
presented herein clearly distinguish these 4 proteinases. The 
data suggest that cathepsin G, tonin , and especially human 
sk in chymotryptic proteinase may play a role in tissue-localized 
angiotensin formation. 
MATERIALS AND METHODS 
(lle5) angiotensin II (A ll) and (lle5) angiote nsin I (AI) (Vega Bio· 
chemica ls, Tucson, Arizona); NaCIO, , 85% H,P04 , and CH,C N [high-
performance liquid chromatography (HPLC) grade] (Fisher Scientific, 
Medford, Massachusetts), asp-a rg-val-tyr a nd ile- his-pro-phe (Penin· 
sula Laboratories, Inc., San Carlos, California), porcine pancreatic o:· 
chymotrypsin (CDI, 49 U/mg) (Worthington, Freehold, New J ersey), 
and BTEE (Sigma Chemica l Co., St. Louis, Missouri) were obtained 
as noted. Suc-arg-tyr-p-ni t roanilide (p-NA), suc(oMe)arg-pro-tyr-p-
NA, bz-a rg-pro- tyr-p-N A, and bz-arg-pro-phe-p-N A were gifts of Kabi 
Diagnostics (Stockholm, Sweden). 
Enzyme Purificat ion 
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Rat peritoneal mast cell chymase was purified to homogeneity from 
rat se rosal mast ce ll s by sequentia l chromatography on Dowex 1-X2 
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and o -tryptop han methyl ester (DTME)-sepharose as desc ribed (15]. 
Pu re rat sali va ry g-land tonin was a gift of Dr . . ). Genest (Montreal, 
Quebec). Human leukocyte cathepsin G was purifi ed to homogeneity 
from t h e granules of fresh human peripheral blood polymorphonuclear 
leukocytes by ap roti nin -sepharose affinity chromatography and car· 
boxymethyl (CM) cellulose cation exchange chromatography 112]. Hu-
man s kin chymotryptic prote inase was highly purified (50%) from 
human sk in by 2.0 M KC! extraction, sephacryl S-200 gel fil trat ion, 
and DTME-sepharose affi ni ty chromatography 14]. Its concentration 
was measured by active site titration with tritium-labeled diisopropyl 
flourop hosphate (DFP) [4] . 
Enzym e Assays 
BTEE hydrolysis was measured by a spectrophotometric assay in 
whic h t he reaction mix ture conta ined 0.04 M Tris with 5 mM CaC!,, 
and 25 % (v/v) methanol at pH 7.8. The sta ndard assay employed 0.50 
mM BTEE as described [1 6]. while a substrate concentration range of 
0.1- 1.0 mM was used for determination of kinetic co nstants. Cleavage 
of BTEE was monitored at 22 ' C using continuous kinetic spectropho· 
tometric analysis at 256 nm. At 256 nm the molar extinction coeffi cient 
of the n et change in optica l density is 964. Higher concentrations of 
BTEE caused substrate inhibition of enzyme act ivities and one unit of 
chymase cleaved 1 ,.,mol of subst rate/min at 22 ' C. Tripeptidep-nitroa n-
ili de ( p-NA) derivatives were assayed at 0.25 or 0.50 mM in 0.04 M Tris 
containing 10 mM CaClz, 0.1 M NaCI, and 10% DMSO at pH 7.8. The 
change in absorban ce was monitored at 405 nm where the molar 
extinction coefficient for free p-NA is 962. Data are expressed as ,.,mol 
substrate hydrolyzed/ min . 
Angiotensin I cleavage was measured by a HPLC assay as described 
[ 17]. HPLC was performed on Beckman Model 144 system using a 4.6 
x 250 mm Altex Ultrasphere 5 ,.,m ODS Cl 8 column employing an 
isocratic perchlorate ion pair reverse -phase system (17]. A now rate of 
}..0 cc/m in and 40% CHaCN were used. 
Kinetic constants were determined by visual examination using 
Lineweaver-Burk analys is of the reciproca l of the reaction vel ocity and 
substrate concentra tion. 
[mmunoprecipitation Assays 
Ochterlony immunop recipi tat ion analysis was carried out usin g mon-
ospecific goat antisera to rat mast cell chymase or cathepsin G [1 2]. 
Ant iserum to rat mast cell chymase was monospecific as it gave single 
precipitation arc and line of ident ity when diffused against purified 
chyrnase or crude extracts of rat peritonea l mast cells. Immunopreci-
pitation plates were prepared and, 2 h before use, were incubated in 
0.01 M Tris, pH 7.4 , 1.0 M NaCI. The latter procedure was necessary 
to prevent nonspecific protein in teractions. 
RESULTS 
Profile of Angiotensin Converting Activity 
To measure angiotensin I cleavage, an isocratic HPLC assay 
was employed (Fig 1) . Asp-arg-val-tyr (peptide a) is formed by 
tyr4 - iles cleavage of angiotensin I or II and is biological~y 
inactive. Ile-his-pro-phe (pept ide b) is also inactive and IS 
formed by tyr4-i ler, cleavage of an giotens in II or by tyr4-ile, a nd 
phe8-his9 cleavage of angiotensin I. Asp-a rg-val -tyr-ile-his-pro-
phe (pept!de c) is ~ormed by cle~vage of the. phe8-h.isg bor:d of 
angiotensm I and 1s the vasoact1ve octapeptide angwtensm II . 
Asp-arg-val-tyr-i le-his-pro-phe-his- leu (peptide d) is angioten-
sin L Synthetic standards for each of these peptides were used 
to calibrate the HPLC assay, and each peptide was quantitated 
by determination of area unde r the appropriate optical density 
peak . . 
Cathepsin G, chymase, tonin, human skin chymotrypt1c pro-
teinase, and chymotrypsin were each incubated at 3.5 X 10- !J M 
with 10 nmol angiotensin I in 100 Jl] 0.01 M Tris, pH 7.4, 0.15 
M NaCI at 37'C. At various times up to 30 min, 20-Jtl aliquots 
were removed from each reaction mixture and angiotensin !-
derived products were quantitated a nd characterized by HPLC 
assay (Fig 1) . Under these conditions, cathepsin G, tonin, and 
human s kin chy motryptic proteinase generated angiotensin II 
from angiotensin I without formation of asp-arg-val-tyr, the 
amino-terminal tetrapeptide of angiotensin I or angiotensin II. 
·-1: 
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FIG l . HPLC assay of angiotensin 1 conversion. a= Amino-term inal 
tetrapeptide of angiote nsin I or II; b = carboxy- terminal tetrapeptide 
of angiotensin II; c = angiotensin II; d = angiotensin I. The number8 
indicate retent ion time, and the optical density (0.0 .) coordinate ex-
tended to 0.16 AUFS. 
TABLE l. Rate of angiotensin !I formation. from angiotensin I by 
various proteinases (3.5 X Jo -• M) · 
Protein ase 
Chymotryptic proteinase 
n-Chymotrypsin 
Ton in 
Cathepsin G 
Chymase 
Species a nd 
orga n source 
Human skin 
Porcine pancreas 
Rat sa livary gland 
Human neut rophil 
Rat mast cell chymase 
Angiotensin 11 
fo rmed pmol/ h 
< 10,000 
1,800 
1,000 
800 
180 
With t he exception of the skin enzyme an<Yiotensin II formation 
was linear. For cathepsin G, ton in , chyma~e, and chymotrypsin, 
the relative reaction rates were calculated (Table I). However 
by 15 min skin proteinase-dependent angioten sin II formatio~ 
was nonlinear due to substrate depletion of approximately 30% 
and the reaction rate is therefore underestimated (Table I). ' 
At all time points, t he major product of chymase and chy-
motrypsin digestion of angiotensin I was asp-arg-val -tyr, and 
chymase formed this peptide at a rate 7 times t hat of t he 
formation of a ngiotensin II. This observation raises the ques-
tion of whether asp-arg-val-tyr is derived from angiotensin I 
substrate or angiotensin II product acting as an intermediate. 
Chymase was incubated with angiotensin II, and asp-arg-val-
tyr and ile- his-pro-phe were detected in equimolar quantities. 
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However, t hey were generated at 3% the rate observed during 
chymase-dependent cleavage of angiotensin I. As ile-h is-pro-
phe, the carboxy-terminal tetrapeptide of angiotensin II , was 
not detected when angiotensi n I was used as substrate, chymase 
must preferent ially cleave the tyr,- il er, bond of angiotensin I 
without significant cleavage of this bond in angiotensin II . 
Since t he human skin chymotryptic prote inase most rapidly 
converted angiotensin I to angiotensin II, it was fu rther evalu-
ated by incubating 1.66, 3.32, and 16.6 X 10- 10 M proteinase 
with 5 X 10_,, M angiote nsin I in 0.01 M Tris, pH 7.4, 0.15 M 
NaC I for 0, 5, 15, 30, and 60 min at 37•c. At each enzyme 
concentration, the formation of angiotensin II was linear, and 
the reaction products, angiotens in II and his- leu, were detected 
in equimolar quan t it ies. The constituent tetrapeptides of an-
giotensin II were not detected. The kinetic constants of this 
reaction for 1.66, 3.32, and 16.6 X 10- 10 M proteinase were 
determined. A Lineweaver-Burk plot of the reciprocal of the 
reaction velocity and substrate concent ration demonstrated 
saturation kinetics (Fig 2). The K., was 6.6 x 10-" M and the 
V.,,., for 1.66, 3.32, and 16.6 X w - lfl M proteinase was 2.14, 6.0, 
and 30.0 nmol angiotensin II produced per hour. The Kc"'' 
calculated as V"',xfpmol of proteinase, was 50/s. 
Relative Activity on BTEE 
Since each enzyme metabolized angiotensin I substrate in a 
unique man ner, they were furth er distinguished by study of 
activity on BTEE. The activ it ies of equimolar amounts of 
chymotryps in, chymase, cathepsin G, human skin chymotryptic 
protei nase, a nd tonin for cleavage of BTEE are distinct for 
each proteinase. At 0.4 mM BTEE, the ratios of initial reaction 
veloc ities were 1(tonin):51(cathepsin G):844(chymase):1020 
(skin chymotryptic proteinase) :1468(chymotrypsin). As shown 
in Table II t he K,.,., value for chymotrypsin is about 6-fold 
higher than the K ent values found for cathepsin G and chymase, 
whereas the K,, value for cathepsin G is 13- and 8-fold higher 
than the va lues for chymase and chymotrypsin , respectively. 
Ton in activity against BTEE was too low for determination of 
kinetic constants. 
12 
11 
KM= 6.6 x1 0" 5M 
Kcat = 50sec·' 
-20 -15-10 -5 0 5 10 15 20 25 30 35 40 
1;[AI]x10-3 (M 1 ) 
F IG 2. Lineweaver-Burk analys is of human skin chymotryptic pro-
te in ase-dependent angiotensin I conversion. To determine t he satura-
tion kinetic consta nts, various concentrations or the prote inase were 
incubated with 1.25, 2.5, 5.0, 10.0, and 20.0 x 10- 5 M a ngiotensin I for 
JO min at 37"C in 0.01 M Tris, pH 7.4 , 0.15 NaCl prior to HPLC assay. 
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TABLE II. Comparison of kinetic constants of each chymotryptic 
proteinase for cleavage of ben.zoyl-1J-tyrusine ethyl ester (BTEEJ 
Hum an Rat Rat Porcine 
cathepsin G chymase Lon in chymotrypsin 
Kcat (s- 1) 11.9 11.9 N" 68 
Km(mM) 8.4 0.65 N" 1.0 
"Ton in cleavage of BTEE was not measurable. 
Immww precipitation A nalysis 
To study the immunologic relationships of the 4 enzymes, 4 
J.L g of each was diffused against monospecific goat antiserum to 
cathepsin G or monospecific goat antise rum to chymase. Anti-
serum to cathepsin G formed a single precipitation arc when 
diffused against cathepsin G but failed to precipitate tonin, 
chymase, or human skin chymotryptic proteinase. Antiserum 
to chymase formed a single precipitation arc when diffused 
against chymase but failed to precipitate tonin , cathepsin G, or 
human skin chymotryptic proteinase. 
DISCUSSION 
Human skin chymotryptic proteinase, human leukocyte ca-
t hepsin G, rat mast cell chymase, and rat salivary gland tonin 
are well-characterized, cell -derived chymotryptic serine pro-
teinases whose biologic functions are not well understood. The 
human skin chymotrypsin-like proteinase, cathepsin G, and 
ton in have each been independent ly recognized to convert 
angiotensin I to angiotensin II [7,13,14]. Rat mast cell chymase 
has not been evaluated with regard to potential participation 
in angiotensin-generating pathways. Using an HPLC assay 
which permits iden t ification of all reaction products and quan-
titates substrate utilization, the angiotensin I converting activ-
ity of equimolar amounts of each enzyme was measured. Under 
the condit ions of these experiments, skin chymotryptic protein-
ase, cathepsin G, and toni n each converted angiotensin I to 
angiotensin II without further degradation of angiotensin II, 
and the relative specific activit ies were distinct for each pro-
teinase (Table I). At 10- • M angiotensin I and equimolar con-
centration of each proteinase, the relative initial velocit ies for 
angiotensin I conversion were 0.8(cathepsin G):l.O(tonin): 
> 10(skin chymotrypt ic proteinase). In contrast to t he 3 pro-
teinases above, rat mast cell chymase generated angiotensin II 
at an apparent rate 25% t hat of cathepsin G, and rapidly 
hydrolyzed the tyr .~-ile,, bond of angiotensin I forming the 
biologically inactive products asp-arg-val -tyr and ile-his-pro-
phe-his-leu. The 4 enzymes were further functionally distin-
guished by t heir differing ini t ial reaction velocities on the 
synthetic substrate BTEE as demonstrated here. In addition, 
the kinetic constants of chymase, cathepsin G, and tonin for 
BTEE cleavage were distinct (Table II) and did not resemble 
that previously reported for t he human skin chymotryptic 
proteinase [ 4]. These experiments clearly demonstrate t hat rat 
tonin is not rat mast cell chymase. The individual identities of 
human skin proteinase and cathepsin G and of rat chymase 
and tonin were confirmed by the immunoprecipitation analysis 
utilizing monospecific, polyclonal antisera. 
Angiotensin I converting activity was initially recognized as 
a plasma dipeptidyl carboxypeptidase which converted angi-
otensin I to angiotensin II and inactivated bradykinin [9,18]. 
ACE is a component of vascular endothelium [ 19) and has been 
ident ified in skin [20] . It requires zinc and is inhibited by 
chelating agents as well as a variety of clinically useful anti-
hypertensive agents including captopril (SQ 20,881) [21) which 
was designed as a convert ing enzyme inhibitor. ACE has been 
purified from procine plasma [22], hog kidney (23 ], and rabbit 
[24), human [25), hog [26) and calf (27) lung. The Km and !{..., 
for human lung enzyme angiotensin I conversion are 7 X 10-5 
M and 13.2/s [24,28). The Km and Kcnc of cathepsin G-dependent 
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a ngiotensin I conversion are 2.2 X 10-·l M a nd 3.1/s, resp ec-
tively . Huma n s kin chy motryptic proteinase a lso converts an -
giotensin I to a ngiotensin II [13). The kinet ic constants a re K , 
= 6.6 X 10- r, M and K,., = 50/s, (Fig 2). The kinetics of this 
enzyme for a ngioten s in I convers ion are cons isten t with a more 
efficient reaction than for t he dipeptidyl carboxypeptidase 
ACE. These results suggest t hat a ngiotens ion I conversion may 
be a physiologic reaction for the human skin enzyme. 
The known bio logic activiti es of angiotensin II a re consistent 
with a potentially important ro le in the microcirculation . An-
giotensin II contracts smooth muscle [8) and enhances vascu lar 
permeability in vitro [29). The nature of angiotens in forming 
and processing in s kin is la rgely unst udied. However, the dermis 
contains ACE as measured by synthetic substrate assay [20] . 
However, skin a ngiotensin I conversion has not been measured 
us ing native peptide substrate . The chymotryptic proteinase of 
human skin and human leukocyte cathepsin G provide unique 
angioten s in II -forming pathways. While stored in different 
cellular compartments, both enzymes may be released in the 
t issue microenvironment. The s kin chymotryptic proteinase is 
foun d in 15-fold increased amounts in skin of patients with 
mastocytosis a nd may be a constituent of t he mast cell [4). 
Release of this e nzyme from mast cells with other vasoactive 
mediators [5) may occur at perivenular locations such as in 
skin where loca l angiotensin II formation may occur. Catheps in 
G is a m ajor constituent of the neutrophil azurophil gra nule 
and would be re leased during cell death or phagocytosis, in s ites 
of neutrophi l accumulation. Thus, angiotensin II production 
might take place in tissue by 3 cellular pathways which require 
different enzymes: endothelial cell-bound ACE; human skin 
chymotryptic proteinase; or neutrophil cathepsin G. 
The authors greatly appreciate the outstanding technical contr ibu -
tions of John Choy and Lloyd l{lickstein. 
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